Navamedic launches Cysticina®, a non-prescription drug for alleviating urinary tract infections

UTI is a common infection experienced most often by women. Approximately 3.5% of all general practitioner inquiries are UTI related and about 440 000 antibiotics prescriptions are prescribed for UTI every year.

In a survey conducted by Respons analytics close to 50% of the women between 18 to 24 responded that they have had UTI at least once during the last year. In the age group 25 to 34 the corresponding share was 39%.

The symptoms of UTI are common enough that most will be able to self-diagnose.

“UTI is a burdensome and often repeating issue for women. We also know that many women will treat the symptoms themselves. Until now there have been few effective non-prescription alternatives available in the pharmacies to treat UTI symptoms and we are therefore pleased that Cysticina® will now be available in Norway”, says Kathrine Gamborg Andreassen, CEO Navamedic.

Cysticina® is Norway’s first non-prescription drug of its kind and is now available at the pharmacy.

About Cysticina® 40 coated tablets:
Traditional use herbal medicinal product used for alleviating symptoms of mild recurrent lower urinary tract infections such as burning sensation during urination and/or frequent urination in women. Should only be used after serious conditions have been excluded by a physician.

The use of a traditional herbal medicine is based exclusively on a long tradition of use. Adequate fluid intake is required during treatment. Do not use in conditions of reduced fluid intake or in case of hypersensitivity to the ingredients. Contact a doctor if the symptoms do not subside after 4 days or worsen during use. Do not use for more than 2 weeks. The use of Cysticina in children and adolescents under 18 years of age is not recommended. Should not be use by pregnant or breastfeeding women due to insufficient data. Read the package leaflet carefully before use.